Crude peptide (revision 26)
Old revision·14:57, 29 Dec 2025·EndotoxinEd
| Crude peptideProcess intermediate | |
|---|---|
| Obtained from | Cleavage of the assembled chain |
| Typical purity | Highly variable; sequence-dependent |
| Principal impurities | Deletion and truncated sequences |
| Topic infobox · conventions | |
Crude peptide is the material obtained immediately after cleavage from the solid support, before any chromatographic purification. It contains the target peptide together with every by-product that accumulated during assembly and cleavage.[1]
Its purity is highly variable and is largely determined by sequence. An easy 10-residue sequence may cleave at high purity; a difficult 40-residue sequence may cleave at well under half. That figure sets the cost and difficulty of everything that follows.[1]
Crude peptide is sold as such in some markets, principally where the purchaser intends to purify it. Material described only as "crude" is not a defective product; it is an intermediate, and describing it accurately is what distinguishes it from a purified one.[2]
What is in it
[edit]The dominant impurities are sequence-related: deletion sequences missing one or more residues where a coupling failed, truncated sequences where a chain was capped, and any peptide bearing residual protecting groups where cleavage was incomplete.[1][3]
Cleavage adds its own. Strongly acidic conditions release reactive cations from the protecting groups, which can alkylate tryptophan, methionine and cysteine unless scavengers capture them; oxidation and, for susceptible sequences, aspartimide formation also occur.
Non-peptide material is present too: scavengers, residual cleavage reagent, and trifluoroacetate. A crude figure quoted as a percentage is normally a chromatographic area percent, so it says nothing about how much of the solid is peptide at all. See Peptide content.[2]
From crude to purified
[edit]Preparative chromatography separates the target from the closely related impurities, and the yield of that step falls as crude purity falls: more material must be discarded to reach a given specification.[1]
| Crude purity | Consequence for purification |
|---|---|
| High | Narrow fraction cut; good recovery |
| Moderate | Wider separation problem; recovery falls |
| Low | Several passes may be required |
This is the mechanism behind the observation, made at Preparative HPLC purification, that the cost difference between 95% and 99% material is not proportional to the difference in the numbers.
It also bears on identity. A crude containing a high proportion of deletion sequences is a crude in which the main peak is less dominant, and identity confirmation by mass becomes correspondingly more important rather than less.[2]
Crude material in the research market
[edit]Where crude material is offered, the honest description is that it is unpurified. Documentation for such material should say so, and a certificate reporting a high purity figure for something described as crude is internally inconsistent.[2]
The reverse risk is more consequential: purified-grade documentation attached to crude material. No analytical determination distinguishes the two by name — the question is simply what the chromatogram shows — which is why an itemised related-substances profile is more informative than a headline figure.
This is a documentary observation about how material is described, not an allegation about any supplier. Material honestly described as crude and priced accordingly is an ordinary product with an ordinary use.[1]
See also
- Solid-phase peptide synthesis
- Preparative HPLC purification
- Resin cleavage
- Area percent purity
- Peptide content
References
- ^ a b c d e Behrendt R, White P, Offer J. "Advances in Fmoc solid-phase peptide synthesis." Journal of Peptide Science 22(1):4–27 (2016). PMID 26785684.
- ^ a b c d United States Pharmacopeia, General Chapter <1503>, Quality Attributes of Synthetic Peptide Drug Substances.
- ^ Merrifield RB. "Solid phase peptide synthesis. I. The synthesis of a tetrapeptide." Journal of the American Chemical Society 85(14):2149–2154 (1963). DOI:10.1021/ja00897a025.
- ^ United States Pharmacopeia, General Chapter <621>, Chromatography.